Ischemic heart disease (IHD) is still the main cause of death in the general population: approximately every 40 seconds, an American suffers from an acute myocardial infarction (MI). Worldwide, in 2015, there was an estimated 7.29 million cases of acute MI. There have been 8.92 million deaths due to IHD in 2015. Of particular concern is that IHD age-standardized mortality showed less decline in the past five years than over the past 25 years. Trends in MI mortality have plateaued and are no longer declining for high-income regions. An explanation for this stagnation could be that networks, strategies, interventions, devices, and drugs for the treatment of MIs have been maximally instituted and optimized. Innovative approaches are necessary to achieve further improvements in patient outcomes following an MI. The aim of this special issue is to analyze and discuss the major unsolved issues involving MIs from basic research to new medical and interventional options, to provide the best management strategies. The invited papers focus on reperfusion injury (mechanisms and potential targets for treatment), left ventricle remodeling after an acute MI, concepts to improve the MI network, and timing and tools to achieve complete revascularization in patients with multivessel disease. Additional topics of interest are new anticoagulants and antiplatelet agents for the acute and chronic phase of an MI, as well as new devices for coronary revascularization. The target population are cardiologists managing MI patients both in the acute and chronic phase. Clinicians will have a complete overview regarding the main issues of the clinical management of MI patients and will be updated on potential current and future solutions to improve the prognosis of their patients.
Prof. Gianluca Campo
Manuscripts should be submitted via our online editorial system at https://imr.propub.com by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website. Research articles, reviews as well as short communications are preferred. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office to announce on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. The Article Processing Charge (APC) in this open access journal is 2200 USD. Submitted manuscripts should be well formatted in good English.
Unsolved questions in the revascularization of older MI patients with multivessel disease
The paradox of the reperfusion injury during MI: mechanims and potential solutions
New generation bioresorbable scaffolds for the treatment of younger MI patients